Skip to Content

IG322 300 mg (Gabapentin 300 mg)

Pill with imprint IG322 300 mg is Yellow, Capsule-shape and has been identified as Gabapentin 300 mg. It is supplied by InvaGen Pharmaceuticals, Inc..

Gabapentin is used in the treatment of postherpetic neuralgia; epilepsy and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Gabapentin 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for IG322 300 mg

Gabapentin 300 mg IG322 300 mg
Gabapentin 300 mg IG322 300 mg
Gabapentin 300 mg IG322 300 mg
Gabapentin 300 mg IG322 300 mg
Gabapentin 300 mg IG322 300 mg

Gabapentin

Imprint
IG322 300 mg
Strength
300 mg
Color
Yellow
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Gamma-aminobutyric acid analogs
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
InvaGen Pharmaceuticals, Inc.
Inactive Ingredients
mannitol, corn starch, magnesium silicate, FD&C Red No. 40, D&C Yellow No. 10, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
31722-0222 Camber Pharmaceuticals, Inc.
60429-0739 Golden State Medical Supply (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.